NCT04290806 2026-01-28
SAPHIR
iOMEDICO AG
Recruiting
Clinical Trials
14 trialsNCT07088354 2025-07-28
DL-ESCC
Tongji Hospital
Recruiting
NCT06490003 2025-07-11
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
City of Hope Medical Center
Recruiting
NCT06169163 2025-05-02
ViSON
Imperial College London
Recruiting
NCT04510129 2025-03-12
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
Recruiting
NCT06504615 2024-12-13
METAGIO
Bristol-Myers Squibb
Recruiting
NCT06710665 2024-11-29
Tumor Regression Grade As Predictor of Adjuvant Therapy
Fujian Medical University Union Hospital
Recruiting
NCT06561178 2024-08-29
Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)
Sun Yat-sen University
Recruiting
NCT06408584 2024-05-21
SCHRT
Anhui Provincial Hospital
Recruiting
NCT06190847 2024-01-05
Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer
Anhui Provincial Hospital
Recruiting
NCT05833594 2023-12-26
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital
Recruiting
NCT05740995 2023-03-21
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Recruiting
NCT05392413 2022-07-06
Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody
Nanfang Hospital, Southern Medical University
Recruiting
NCT04522687 2020-08-21
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
Shanghai Cancer Hospital, China
Recruiting